Detalhe da pesquisa
1.
DecodeME: community recruitment for a large genetics study of myalgic encephalomyelitis / chronic fatigue syndrome.
BMC Neurol
; 22(1): 269, 2022 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35854226
2.
Novel 6-aminofuro[3,2-c]pyridines as potent, orally efficacious inhibitors of cMET and RON kinases.
Bioorg Med Chem Lett
; 23(15): 4381-7, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23773865
3.
Typing myalgic encephalomyelitis by infection at onset: A DecodeME study.
NIHR Open Res
; 3: 20, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37881452
4.
Potent and selective cyclohexyl-derived imidazopyrazine insulin-like growth factor 1 receptor inhibitors with in vivo efficacy.
Bioorg Med Chem Lett
; 21(4): 1176-80, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21251824
5.
Commissioning. A prescription for medicine management.
Health Serv J
; 123(6363): 19-21, 2013 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24199424
6.
Discovery of novel insulin-like growth factor-1 receptor inhibitors with unique time-dependent binding kinetics.
ACS Med Chem Lett
; 4(7): 627-31, 2013 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-24900721
7.
Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin.
Mol Cancer Ther
; 10(8): 1394-406, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21673091
8.
Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IR.
ACS Med Chem Lett
; 1(9): 510-5, 2010 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24900240